Since its first emergence in late 2019, severe acute respiratory syndrome coronavirus-2 has
claimed more than 6.5 million lives worldwide and continues to infect hundreds of thousands …

COVID-19 Vaccines, which include mRNA and inactivated vaccines, have been proven
effective and safe for infants and children aged more than six months in reducing the …

Background COVID-19 in paediatric ages could result in hospitalizations and death. In
addition, excluding children from vaccination could turn them into reservoirs of the SARS …

Acute respiratory infections are the leading cause of death and illness in children under 5
years old and represent a significant burden in older adults. Primarily caused by viruses …

Introduction The rapid development of COVID-19 vaccines has provided crucial tools for
pandemic control, but the occurrence of vaccine-related adverse events (AEs) underscores …

Background Coronavirus disease 2019 (COVID-19) pandemic scared the whole world at the
end of 2019, which is a communicable respiratory disease caused by severe acute …

Importance The protein-based SARS-CoV-2 vaccines FINLAY-FR-2 (Soberana 02) and
FINLAY-FR-1A (Soberana Plus) showed good safety and immunogenicity in phase 1 and 2 …

Humanity did surprisingly well so far, considering how unprepared it was to respond to the
coronavirus disease 2019 (COVID-19) threat. By blending old and ingenious new …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant protein
vaccines have been widely used in the real world and shown good protective effects. A …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused huge social
and economic distress. Given its rapid spread and the lack of specific treatment options …